Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 971

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 971
---
) agrees to observe the terms of this Section8.1(d) with respect to such information or (B) is bound by an obligation of confidentiality to the Stockholders Representative of at least as high a standard as those imposed on the Stockholders Representative under this Section8.1(d); provided, however, that Parent may in good faith designate any information provided to the Stockholders Representative to be sensitive and proprietary as to Parent, the Surviving Company, or any of their Affiliates, in which case such information may not be disclosed by the Stockholders Representative to the stockholders; provided, further, that with respect to any such sensitive and proprietary information, Parent and the Stockholders Representative shall work together in good faith to prepare a summary or abstract of such information that may be disclosed by the Stockholders Representative to the stockholders.

<div align='center'>A-52</div>

Section 8.2 Nonsurvival of Representations and Warranties. None of the representations, warranties, covenants or agreements in this Agreement or in any instrument delivered pursuant to this Agreement shall survive the Effective Time, other than those covenants or agreements of the parties which by their terms apply, or are to be performed in whole or in part, after the Effective Time. Section 8.3 Notices. All notices and other communications hereunder shall be in writing and shall be deemed duly given (a) on the date of delivery if delivered personally, or if by e-mail,upon written (including electronic) confirmation of receipt by e-mailor otherwise, (b) on the first (1 st) Business Day following the date of dispatch if delivered utilizing a next-dayservice by a recognized next-daycourier or (c) on the earlier of confirmed receipt or the fifth (5 th) Business Day following the date of mailing if delivered by registered or certified mail, return receipt requested, postage prepaid. All notices hereunder shall be delivered to the addresses set forth below, or pursuant to such other instructions as may be designated in writing by the party to receive such notice:

| (i) | if to Parent, Merger Sub I, Merger Sub II or the Surviving Company, to: |

TuHURA Biosciences, Inc. 10500 University Center Drive, Suite 110 Tampa, FL 33612 Attention: Dan Dearborn, Chief Financial Officer E-mail:ddearborn@tuhurabio.com with a copy (which shall not constitute notice) to: Foley & Lardner LLP